pentazocine has been researched along with Age-Related Memory Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiramatsu, M; Hoshino, T | 1 |
Kobayashi, T; Matsuno, K; Mita, S; Nakata, K; Okamoto, K; Senda, T | 1 |
2 other study(ies) available for pentazocine and Age-Related Memory Disorders
Article | Year |
---|---|
Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors.
Topics: Acetic Acid; Analgesics, Opioid; Analysis of Variance; Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Isomerism; Male; Maze Learning; Memory Disorders; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Pentazocine; Propylamines; Receptors, Opioid, kappa; Receptors, sigma; Scopolamine | 2005 |
Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats.
Topics: Animals; Avoidance Learning; Guinea Pigs; Ibotenic Acid; Male; Memory; Memory Disorders; Nootropic Agents; Pain Measurement; Pentazocine; Piperazines; Prosencephalon; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, sigma; Scopolamine; Tacrine | 1996 |